Viewing nowDaewoong Bio Atorvastatin Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 201307002 · Approved 2013.04.19 · Insurance code 694000560
Reduction of the risk of myocardial infarction and stroke, and treatment of hyperlipidemia
This medication is used to reduce the risk of cardiovascular disease. It particularly lowers the risk of myocardial infarction and stroke in adults over 55 years of age with multiple risk factors such as smoking, hypertension, and low HDL cholesterol, as well as in patients with type 2 diabetes. It also reduces the risk of hospitalization due to myocardial infarction, stroke, vascular surgery, and congestive heart failure in adults who already have coronary artery disease. For the treatment of hyperlipidemia, it decreases LDL cholesterol and total cholesterol in patients with primary hypercholesterolemia and dyslipidemia while increasing HDL cholesterol. It is especially effective in patients who do not respond to dietary therapy. It is also used as an adjunctive therapy for the treatment of familial hypercholesterolemia in children aged 10 to 17 years. This medication effectively improves cardiovascular diseases and hyperlipidemia.
For the treatment of hyperlipidemia, the recommended initial dose is 10 mg once daily, and if needed, it may be started at 20 mg or 40 mg once daily. It is administered in the range of 10 to 80 mg once daily, and individual adjustments should be made based on treatment goals and patient response. Lipid levels should be analyzed within 2 to 4 weeks after starting treatment to adjust the dosage accordingly. The goal of treatment is to lower LDL cholesterol levels, so it is recommended to use LDL cholesterol levels for evaluating the initiation of treatment and treatment response. However, if LDL cholesterol levels cannot be used, total cholesterol levels may be monitored for treatment response. For patients with homozygous familial hypercholesterolemia, the administered dosage is 10 to 80 mg once daily, in conjunction with other lipid-lowering treatments (e.g., LDL apheresis) or when such lipid-lowering treatments are not possible.
For pediatric patients (ages 10 to 17) with heterozygous familial hypercholesterolemia, the recommended initial dose is 10 mg once daily, with a maximum dose of 20 mg once daily. The dosage should be adjusted at intervals of at least 4 weeks according to the treatment goals.
This medication may cause muscular symptoms, so if muscle pain or weakness is severe or if creatine kinase levels significantly increase, the patient should stop taking the medication immediately and consult a doctor. This medication can affect liver function, so it should not be used in patients with liver disease or elevated liver function test results, and regular liver function tests should be performed during treatment. Women who are pregnant or may become pregnant, and breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraception while on this medication. This medication should not be used in children under 10 years old, and elderly patients or those with reduced kidney function are at higher risk for myopathy and should exercise caution. There are many drug interactions, so it is imperative to inform the doctor, especially when used in conjunction with certain antibiotics, antifungals, HIV medications, and some lipid-lowering agents, as dose adjustments or cessation may be needed. If fever, weakness, or unexplained muscle pain occurs during treatment, healthcare professionals should be notified immediately, and if severe skin rash or allergic reactions occur, the medication should be discontinued. The consumption of grapefruit juice should be avoided as it may increase blood concentration levels of the medication. There is no specific antidote for overdose, so treatment should be symptomatic, and it is important to keep this medication out of the reach of children.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, lightning-like headache, seizures, confusion, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help maintain the efficacy of the medication.
White round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.